173 related articles for article (PubMed ID: 28905458)
1. Phosphorylation of ETS-1 is a critical event in DNA polymerase iota-induced invasion and metastasis of esophageal squamous cell carcinoma.
He C; Wu S; Gao A; Su Y; Min H; Shang ZF; Wu J; Yang L; Ding WQ; Zhou J
Cancer Sci; 2017 Dec; 108(12):2503-2510. PubMed ID: 28905458
[TBL] [Abstract][Full Text] [Related]
2. DNA polymerase iota (Pol ι) promotes invasion and metastasis of esophageal squamous cell carcinoma.
Zou S; Shang ZF; Liu B; Zhang S; Wu J; Huang M; Ding WQ; Zhou J
Oncotarget; 2016 May; 7(22):32274-85. PubMed ID: 27057634
[TBL] [Abstract][Full Text] [Related]
3. DNA polymerase iota promotes EMT and metastasis of esophageal squamous cell carcinoma by interacting with USP7 to stabilize HIF-1α.
Gao A; Zhang M; Zhu SQ; Zou S; Chen H; Li X; He C; Zhou L; Mei Y; Ding W; Zhou J; Zhou Y; Cao Y
Cell Death Dis; 2024 Feb; 15(2):171. PubMed ID: 38402183
[TBL] [Abstract][Full Text] [Related]
4. Elevated DNA polymerase iota (Poli) is involved in the acquisition of aggressive phenotypes of human esophageal squamous cell cancer.
Sun H; Zou S; Zhang S; Liu B; Meng X; Li X; Yu J; Wu J; Zhou J
Int J Clin Exp Pathol; 2015; 8(4):3591-601. PubMed ID: 26097541
[TBL] [Abstract][Full Text] [Related]
5. PFN2, a novel marker of unfavorable prognosis, is a potential therapeutic target involved in esophageal squamous cell carcinoma.
Cui XB; Zhang SM; Xu YX; Dang HW; Liu CX; Wang LH; Yang L; Hu JM; Liang WH; Jiang JF; Li N; Li Y; Chen YZ; Li F
J Transl Med; 2016 May; 14(1):137. PubMed ID: 27188458
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of miR-191 Predicts Poor Prognosis and Promotes Proliferation and Invasion in Esophageal Squamous Cell Carcinoma.
Gao X; Xie Z; Wang Z; Cheng K; Liang K; Song Z
Yonsei Med J; 2017 Nov; 58(6):1101-1110. PubMed ID: 29047233
[TBL] [Abstract][Full Text] [Related]
7. DNA Polymerase Iota Promotes Esophageal Squamous Cell Carcinoma Proliferation Through Erk-OGT-Induced G6PD Overactivation.
Su Z; Gao A; Li X; Zou S; He C; Wu J; Ding WQ; Zhou J
Front Oncol; 2021; 11():706337. PubMed ID: 34354953
[TBL] [Abstract][Full Text] [Related]
8. RNF113A promotes the proliferation, migration and invasion, and is associated with a poor prognosis of esophageal squamous cell carcinoma.
Wang L; Hou Z; Hasim A; Abuduerheman A; Zhang H; Niyaz M; Awut I; Upur H; Sheyhidin I
Int J Oncol; 2018 Mar; 52(3):861-871. PubMed ID: 29393393
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic silencing of HIC1 promotes epithelial-mesenchymal transition and drives progression in esophageal squamous cell carcinoma.
Li P; Liu X; Dong ZM; Ling ZQ
Oncotarget; 2015 Nov; 6(35):38151-65. PubMed ID: 26510908
[TBL] [Abstract][Full Text] [Related]
10. Loss of miR-200b promotes invasion via activating the Kindlin-2/integrin β1/AKT pathway in esophageal squamous cell carcinoma: An E-cadherin-independent mechanism.
Zhang HF; Alshareef A; Wu C; Li S; Jiao JW; Cao HH; Lai R; Xu LY; Li EM
Oncotarget; 2015 Oct; 6(30):28949-60. PubMed ID: 26334393
[TBL] [Abstract][Full Text] [Related]
11. High MLL2 expression predicts poor prognosis and promotes tumor progression by inducing EMT in esophageal squamous cell carcinoma.
Abudureheman A; Ainiwaer J; Hou Z; Niyaz M; Turghun A; Hasim A; Zhang H; Lu X; Sheyhidin I
J Cancer Res Clin Oncol; 2018 Jun; 144(6):1025-1035. PubMed ID: 29532228
[TBL] [Abstract][Full Text] [Related]
12. RAD18 promotes the migration and invasion of esophageal squamous cell cancer via the JNK-MMPs pathway.
Zou S; Yang J; Guo J; Su Y; He C; Wu J; Yu L; Ding WQ; Zhou J
Cancer Lett; 2018 Mar; 417():65-74. PubMed ID: 29306013
[TBL] [Abstract][Full Text] [Related]
13. High expression of Collagen Triple Helix Repeat Containing 1 (CTHRC1) facilitates progression of oesophageal squamous cell carcinoma through MAPK/MEK/ERK/FRA-1 activation.
Wang C; Li Z; Shao F; Yang X; Feng X; Shi S; Gao Y; He J
J Exp Clin Cancer Res; 2017 Jun; 36(1):84. PubMed ID: 28645305
[TBL] [Abstract][Full Text] [Related]
14. Ets-1 and VEGF expression correlates with tumor angiogenesis, lymph node metastasis, and patient survival in esophageal squamous cell carcinoma.
Mukherjee T; Kumar A; Mathur M; Chattopadhyay TK; Ralhan R
J Cancer Res Clin Oncol; 2003 Jul; 129(7):430-6. PubMed ID: 12851814
[TBL] [Abstract][Full Text] [Related]
15. Filamin C promotes lymphatic invasion and lymphatic metastasis and increases cell motility by regulating Rho GTPase in esophageal squamous cell carcinoma.
Tanabe K; Shinsato Y; Furukawa T; Kita Y; Hatanaka K; Minami K; Kawahara K; Yamamoto M; Baba K; Mori S; Uchikado Y; Maemura K; Tanimoto A; Natsugoe S
Oncotarget; 2017 Jan; 8(4):6353-6363. PubMed ID: 28031525
[TBL] [Abstract][Full Text] [Related]
16. Cripto-1 acts as a functional marker of cancer stem-like cells and predicts prognosis of the patients in esophageal squamous cell carcinoma.
Liu Q; Cui X; Yu X; Bian BS; Qian F; Hu XG; Ji CD; Yang L; Ren Y; Cui W; Zhang X; Zhang P; Wang JM; Cui YH; Bian XW
Mol Cancer; 2017 Apr; 16(1):81. PubMed ID: 28431580
[TBL] [Abstract][Full Text] [Related]
17. Eukaryotic translation initiation factor 3B accelerates the progression of esophageal squamous cell carcinoma by activating β-catenin signaling pathway.
Xu F; Xu CZ; Gu J; Liu X; Liu R; Huang E; Yuan Y; Zhao G; Jiang J; Xu C; Chu Y; Lu C; Ge D
Oncotarget; 2016 Jul; 7(28):43401-43411. PubMed ID: 27270324
[TBL] [Abstract][Full Text] [Related]
18. DNA polymerase iota (Pol ι) promotes the migration and invasion of breast cancer cell via EGFR-ERK-mediated epithelial to mesenchymal transition.
Zou S; Xu Y; Chen X; He C; Gao A; Zhou J; Chen Y
Cancer Biomark; 2019; 24(3):363-370. PubMed ID: 30829610
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of MicroRNA-644a Promotes Esophageal Squamous Cell Carcinoma Aggressiveness and Stem Cell-like Phenotype via Dysregulation of PITX2.
Zhang JX; Chen ZH; Xu Y; Chen JW; Weng HW; Yun M; Zheng ZS; Chen C; Wu BL; Li EM; Fu JH; Ye S; Xie D
Clin Cancer Res; 2017 Jan; 23(1):298-310. PubMed ID: 27407092
[TBL] [Abstract][Full Text] [Related]
20. BRCA1-Associated Protein Increases Invasiveness of Esophageal Squamous Cell Carcinoma.
Zhao Y; Wei L; Shao M; Huang X; Chang J; Zheng J; Chu J; Cui Q; Peng L; Luo Y; Tan W; Tan W; Lin D; Wu C
Gastroenterology; 2017 Nov; 153(5):1304-1319.e5. PubMed ID: 28780075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
